Specialty Pharmacy

Biomarker identification may improve abatacept (Orencia) treatment for rheumatoid arthritis.

A look at last week's top stories in the world of pharmacy.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.

Patients with rheumatoid arthritis who switched to biologics or triple therapy had a longer time to treatment failure versus augmented oral methotrexate.

Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.

Several modalities found to be effective in the triage of psoriasis patients with musculoskeletal symptoms, according to a study presented at the 2017 American College of Rheumatology meeting.

Current treatment options for dermatomyositis may be ineffective for some patients, according to a study presented at the American College of Rheumatology Annual Meeting.

Medivir to present positive data at the annual meeting of the American College of Rheumatology.

Top news of the day from across the healthcare landscape.

Top news of the week from Specialty Pharmacy Times.

Unapproved products containing cannabidiol claim to prevent or cure cancer.

Changes to 340B reimbursement will drastically lower out-of-pocket costs for Medicare beneficiaries.

Glucose is crucial for the growth of brain cancer cells.

As a part of the continuing effort to increase awareness and celebrate the pharmacy profession, Pharmacy Times and Specialty Pharmacy Times are partnering to launch the #APharmacistIs campaign.

Norepinephrine may increase blood vessel growth in prostate cancer tumors.

Top news of the day from across the healthcare landscape.

Human genome sequence variations can have a significant impact on the efficacy of HIV antiviral therapy.

The #APharmacistIs campaign aims to increase awareness about the value of pharmacists.

Many new antiviral drugs that treat hepatitis C have similar efficacy, but come with different advantages and disadvantages.

HIV-positive children administered antiretroviral therapy have changes in their white matter brain tissue.

The addition of arsenic trioxide to standard therapy could triple glioblastoma survival.

Top news of the day from across the healthcare landscape.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what role pharmacists have in combating the opioid epidemic.

Some therapies approved in the United States are either fully manufactured overseas or made domestically but contain some foreign ingredients.

Medicare-insured patients with heart disease had the greatest access to PCSK9 inhibitors.

Acalabrutinib (Calquence) found to improve overall response rate among patients with mantle cell lymphoma.

Ozanimod may slow multiple sclerosis progression more than first-line therapy.

Bevacizumab (Avastin) may improve progression-free survival among treatment-naïve patients with ovarian cancer.